Ardelyx, Inc.

US$2.88As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:ARDXHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (13.49%)
Div yield —
ROE (34.85%)
Biotechnology
Beta (5Y) 0.77
PE TTM —
TSR TTM (52.48%)
Mkt cap US$724.0M
ROIC (5.38%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$2.79
(3.16%)
(81.58%)
Buy 11|9|1|2|0
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.04
0.05
0.05
0.06
(5.59%)
5.05%
19.74%
35.66%
Revenue$M
40.97
40.62
42.80
44.40
14.61%
9.24%
12.64%
12.52%
Peers (US$724.0M)
Cap (US$)
PE
723.1M
4.629x
733.7M
—
Capital
TTM
5Y
10Y
Leveragex
0.644
0.076
0.076
EBIT/Intx
1.368
0.736
0.729
Own earn%
(43.93)
41.31
36.23
Sh yield%
52.01
30.48
26.39
Owners
Insiders/Inst%
10.26
51.54
Short interest%
4.30
SBC / revenue%
1.83
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
6
Op margin range%
3–6
$1 testx
0.0
Incr. ROIC%
55